References
1. Wong CY, Helm MA, Kalb RE, Helm TN, Zeitouni NC. The presentation, pathology, and current management strategies of cutaneous metastasis.N Am J Med Sci . 2013;5(9):499-504. doi:10.4103/1947-2714.118918.
2. Spratt DE, Gordon Spratt EA, Wu S, et al. Efficacy of skin-directed therapy for cutaneous metastases from advanced cancer: a meta-analysis.J Clin Oncol . 2014;32(28):3144-3155. doi:10.1200/JCO.2014.55.4634.
3. Oike T, Adachi A, Shirai K, Ohno T. Unresectable cutaneous metastatic tumor in the arm that underwent complete remission after radiotherapy.Clin Case Rep . 2020;8(12):3542-3544. doi:10.1002/ccr3.3119.
4. Lok BH, Jiang G, Gutiontov S, et al. Palliative head and neck radiotherapy with the RTOG 8502 regimen for incurable primary or metastatic cancers. Oral Oncol . 2015;51(10):957-962. doi:10.1016/j.oraloncology.2015.07.011.
5. Toya R, Saito T, Yamaguchi K, et al. Hypofractionated palliative volumetric modulated arc radiotherapy with the Radiation Oncology Study Group 8502 “QUAD shot” regimen for incurable head and neck cancer.Radiat Oncol . 2020;15(1):123. doi:10.1186/s13014-020-01548-w.
6. Mirmohammad Sadeghi H, Karimi A, Rahpeima A, Derakhshan S. Salivary duct carcinoma with late distant brain and cutaneous metastasis: A case report. Iran J Pathol . 2020;15(3):521-525. doi:10.30699/ijp.2020.103326.2039.
7. Chakari W, Andersen L, Andersen JL. Cutaneous metastases from salivary duct carcinoma of the submandibular gland. Case Rep Dermatol . 2017;9(3):254-258. doi:10.1159/000485371.
8. Perez DE, Magrin J, de Almeida OP, Kowalski LP. Multiple cutaneous metastases from a parotid adenoid cystic carcinoma. Pathol Oncol Res . 2007;13(2):167-169. doi:10.1007/BF02893495.
9. Arase S, Sanuki N, Matsuura H. Cutaneous metastasis of prostate carcinoma treated with electron radiotherapy. IJU Case Rep . 2019;2(4):190-192. doi:10.1002/iju5.12078.
10. Spanos W Jr, Guse C, Perez C, Grigsby P, Doggett RL, Poulter C. Phase II study of multiple daily fractionations in the palliation of advanced pelvic malignancies: preliminary report of RTOG 8502. Int J Radiat Oncol Biol Phys . 1989;17(3):659-661. doi:10.1016/0360-3016(89)90120-x.
11. Corry J, Peters LJ, Costa ID, et al. The “QUAD SHOT”—a phase II study of palliative radiotherapy for incurable head and neck cancer.Radiother Oncol . 2005;77(2):137-142. doi:10.1016/j.radonc.2005.10.008.
12. Kil WJ, Camphausen K, Cho IH. Clinical and radiobiological consideration of cyclical hypofractionated radiation therapy also known as QUAD Shot for neglected skin cancer disfiguring the face of a non-compliant patient who was refusing surgery and protracted radiation therapy: case report. Radiat Oncol J . 2019;37(2):143-148. doi:10.3857/roj.2019.00248.
13. Brockwell M, Husain M, Verschraegen C, Wu R, Tinoco G. Case report: the power of immunotherapy in advanced cutaneous squamous cell carcinoma. Front Oncol . 2022;12:1081118. doi:10.3389/fonc.2022.1081118.
14. Gamez ME, Agarwal M, Hu KS, Lukens JN, Harrison LB. Hypofractionated palliative radiotherapy with concurrent radiosensitizing chemotherapy for advanced head and neck cancer using the ”QUAD-SHOT regimen”.Anticancer Res. 2017;37(2):685-691. doi:10.21873/anticanres.11364.
15. Carrascosa LA, Yashar CM, Paris KJ, Larocca RV, Faught SR, Spanos WJ. Palliation of pelvic and head and neck cancer with paclitaxel and a novel radiotherapy regimen. J Palliat Med . 2007;10(4):877-881. doi:10.1089/jpm.2006.0192.